Published on March 29th, 2017 | by TFS0
TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward Tumaian as VP Global Clinical Development
TFS is pleased to announce the appointment of Dr. Bassem Saleh and Mr. Ed Tumaian, two global executive positions in Medical Affairs and Clinical Development. Dr. Saleh and Mr. Tumaian will be joining the Operational Leadership Team and will report to Dr. Montse Barceló, Chief Operating Officer at TFS.
Dr. Bassem Saleh comes to TFS with 10 years of medical- and scientific expertise gained across leading biopharmaceutical companies and global CROs with extensive experience in drug development and oncology. Dr. Saleh joins TFS from Premier Research, where he was working as Vice President, Medical Affairs and heading up Medical, Pharmacovigilance and Informatics. Reporting to Dr. Saleh will be the heads of regulatory affairs, pharmacovigilance, medical writing, feasibility, medical consulting and TFS Evidence™ the real-world evidence team. Dr. Saleh is a trained oncologist and pharmaceutical physician, he received his MD from the Lebanese University and his CCT and FFPM from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians in the UK. Dr. Saleh will be based at the TFS office in Uxbridge, UK.
“It is very exciting to be part of a company going through therapeutic focus, exponential growth and technological transformation. TFS thrives on providing broad and unique offerings to clients and meeting their needs in a rapidly changing market. It is a real privilege to be part of highly experienced and creative teams at TFS, we go hand in hand with our clients to improve personalized patient care and protect patient safety”, says Dr. Bassem Saleh.
Mr. Edward Tumaian comes to TFS with 25 years of clinical development expertise. Ed has worked in several senior managerial positions within clinical development at Novartis, AstraZeneca, and Sanofi. Ed joins TFS from QuintilesIMS where he was working as Sr. Director, Project Leadership in Clinical Operations and responsible for Portfolio Oversight and Innovative Solutions. Reporting to Ed will be the service functions of project management, clinical monitoring, data management and biostatistics involved in predominately Phase II and III trials. Ed received his B.S. Biology degree from Villanova University. Ed will be based at the TFS US headquarters in Princeton, NJ.
“Joining TFS is part of my career journey, as making a difference in bringing medicines to patients through clinical development continues to be the driving factor that TFS embraces. Responsible for ensuring quality, while encouraging and translating strategic vision into successful delivery for our customers with focused alignment on shared goals and objectives to reduce ambiguity and drive success through enhanced trust and confidence”, says Mr. Edward Tumaian.
“We are proud to announce that Bassem Saleh and Ed Tumaian have joined TFS bringing a wealth of experience within their respective fields. TFS is committed to outstanding customer relationships and this starts with attracting the best talent as we successfully continue to manage a higher degree of project complexity throughout the clinical development cycle and post-approval phases”, says Dr. Montse Barceló, COO.
For further information please contact:
Dr. Montse Barceló, Chief Operating Officer (COO)
Phone: +34 647 409 222